Mangalam Organics Ltd is Rated Sell

2 hours ago
share
Share Via
Mangalam Organics Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 August 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Mangalam Organics Ltd is Rated Sell

Current Rating and Its Significance

The 'Sell' rating assigned to Mangalam Organics Ltd indicates a cautious stance for investors, suggesting that the stock may underperform relative to the broader market or sector peers in the near to medium term. This rating is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential and risk profile.

Quality Assessment

As of 29 August 2026, Mangalam Organics exhibits below-average quality metrics. The company’s long-term fundamental strength remains weak, with a compounded annual growth rate (CAGR) of operating profits declining at -13.51% over the past five years. This negative growth trend highlights challenges in sustaining profitability and operational efficiency. Additionally, the average return on equity (ROE) stands at a modest 6.49%, indicating limited profitability generated per unit of shareholders’ funds. The company’s ability to service debt is also constrained, reflected in a high Debt to EBITDA ratio of 4.09 times, which raises concerns about financial leverage and risk.

Valuation Perspective

Despite the quality concerns, Mangalam Organics currently presents an attractive valuation profile. The stock’s market capitalisation remains in the microcap segment, which often entails higher volatility but can offer value opportunities for discerning investors. The valuation grade suggests that the stock is priced favourably relative to its earnings and asset base, potentially providing a margin of safety. However, attractive valuation alone does not offset the underlying fundamental weaknesses and financial risks.

Financial Trend Analysis

The financial trend for Mangalam Organics is largely flat, signalling stagnation in recent performance. The latest six-month profit after tax (PAT) figure of ₹13.25 crores has declined by 23.72%, underscoring ongoing profitability pressures. Institutional investor participation has also waned, with a reduction of 1.42% in their stake over the previous quarter, leaving them with a modest 2.21% holding. This decline in institutional interest may reflect concerns about the company’s growth prospects and financial health, as these investors typically possess superior analytical resources.

Technical Outlook

From a technical standpoint, the stock shows mildly bullish signals as of 29 August 2026. The one-day price change was +1.32%, and the stock has gained 7.42% over the past week. However, these short-term gains are tempered by negative returns over longer periods: -8.70% in one month, -12.33% in three months, and -8.47% over the past year. The stock’s performance has also lagged behind the BSE500 index across multiple time frames, indicating relative underperformance in both near and medium terms.

Stock Returns and Market Performance

Currently, Mangalam Organics has delivered mixed returns. While it has posted a positive 23.18% return over the last six months and a modest 3.06% year-to-date gain, the one-year return remains negative at -8.47%. This inconsistency in returns reflects the company’s volatile operational environment and market sentiment. The stock’s underperformance relative to broader market indices suggests that investors should exercise caution and closely monitor developments before committing capital.

Implications for Investors

The 'Sell' rating on Mangalam Organics Ltd serves as a signal for investors to carefully evaluate the risks associated with the stock. The combination of weak long-term fundamentals, flat financial trends, and below-average quality metrics outweighs the currently attractive valuation and mild technical optimism. Investors should consider these factors in the context of their portfolio objectives and risk tolerance. For those seeking stable growth or income, alternative opportunities with stronger fundamentals may be preferable.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Summary of Key Metrics as of 29 August 2026

Mangalam Organics Ltd’s Mojo Score currently stands at 44.0, corresponding to a 'Sell' grade. This reflects a 16-point improvement from the previous 'Strong Sell' rating of 28, updated on 24 August 2026. Despite this improvement, the score remains below the threshold for a neutral or positive recommendation. The company’s financial and operational indicators continue to signal caution, with persistent challenges in profitability growth and debt management.

Sector and Market Context

Operating within the commodity chemicals sector, Mangalam Organics faces cyclical pressures and competitive dynamics that impact earnings stability. The microcap status of the company adds an additional layer of risk due to lower liquidity and higher susceptibility to market sentiment swings. Investors should weigh these sector-specific factors alongside the company’s individual performance when making investment decisions.

Conclusion

In conclusion, Mangalam Organics Ltd’s current 'Sell' rating by MarketsMOJO reflects a balanced assessment of its fundamental weaknesses, flat financial trends, and modest technical signals, despite an attractive valuation. The rating update on 24 August 2026 signals a slight improvement in outlook, but the stock’s overall profile remains cautious. Investors are advised to consider these insights carefully and monitor ongoing developments before increasing exposure to this stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News